BG ALIUD / STADAPHARM GbR, betapharm Arzneimittel GmbH secures contract for Pharmaceutical products - Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Bosutinib, ATC L01EA04 for the period 01102024 - 30092026

Germany, Jan. 13 -- Germany based BG ALIUD / STADAPHARM GbR, betapharm Arzneimittel GmbH has secured contract from DAK-Gesundheit for Pharmaceutical products - Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Bosutinib, ATC L01EA04 for the period 01102024 - 30092026. The value of the contract is not disclosed.

Published by HT Digital Content Services with permission from Pivotal Sources....